Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (2111)	6/10/2003 4:14:23 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 2243

>> and a YTD-percentage of + 318% << So.... does that make your 50-bagger candidate about a 15-bagger to completion? (that is, GREAT CALL!)

To: Icebrg who wrote (2111)	6/11/2003 10:10:54 AM
From: Icebrg	Read Replies (1) \| Respond to of 2243

>>SPPI - Spectrum Pharmaceuticals>> [And now we know a little bit more about yesterday's price rise. Note, however that in this indication a complete response should more or less be the norm. The tumor is first surgically removed and then chemo or bacillus calmette (!) is injected to take care of whatever that was left behind by the knife. But still, positive news. Erik] Spectrum Reports Positive Phase 1 Data; Will Initiate Phase 2 Study of Eoquin(TM) in Superficial Bladder Cancer Wednesday June 11, 10:00 am ET Complete Response Reported by Investigator in All Five Patients Treated in Phase 1 Eoquin(TM) was Well Tolerated With no Systemic Toxicity IRVINE, Calif., June 11 /PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI - News) today reported a complete response in each of the first five patients treated with its superficial bladder cancer drug, Eoquin. Patients received six increasing doses of Eoquin over a period of six weeks, which, in each case, resulted in the complete disappearance of the tumors. The response was confirmed by biopsy, and follow-up to determine ongoing remission continues. Message 19022119